CN114716519A - L-serine transport protein and application thereof in improving yield of serine - Google Patents

L-serine transport protein and application thereof in improving yield of serine Download PDF

Info

Publication number
CN114716519A
CN114716519A CN202210515655.7A CN202210515655A CN114716519A CN 114716519 A CN114716519 A CN 114716519A CN 202210515655 A CN202210515655 A CN 202210515655A CN 114716519 A CN114716519 A CN 114716519A
Authority
CN
China
Prior art keywords
serine
ala
leu
val
ncgl0255
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210515655.7A
Other languages
Chinese (zh)
Other versions
CN114716519B (en
Inventor
张晓梅
黄易凡
高宇洁
叶锦方
史劲松
许正宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202210515655.7A priority Critical patent/CN114716519B/en
Publication of CN114716519A publication Critical patent/CN114716519A/en
Application granted granted Critical
Publication of CN114716519B publication Critical patent/CN114716519B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/06Alanine; Leucine; Isoleucine; Serine; Homoserine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses an L-serine transport protein and application thereof, belonging to the technical field of biological engineering. On the basis of researching amino acid transporters, the invention provides that NCgl0255 sequence in corynebacterium glutamicum has the function of transporting L-serine. The invention further applies NCgl0255 to an L-serine production strain to improve the yield of L-serine, so that the accumulation amount of L-serine reaches 29.58 g/L.

Description

L-serine transport protein and application thereof in improving homoserine yield
Technical Field
The invention belongs to the technical field of biological engineering, and particularly relates to an L-serine transport protein and application thereof in improving the yield of homoserine.
Background
L-serine is a non-essential amino acid and has wide application in the fields of medicines, foods, cosmetics and the like. The corynebacterium glutamicum is a food safety strain and is widely applied to production of amino acids such as L-glutamic acid, L-lysine, L-valine and the like. However, the general Corynebacterium glutamicum cannot utilize sugar raw materials to produce L-serine by fermentation.
At present, research on L-serine production by Corynebacterium glutamicum at home and abroad focuses on molecular modification of synthesis and degradation pathways, Stolz and the like use Corynebacterium glutamicum ATCC13032 which does not produce L-serine as an original strain, and the L-serine yield is 36.2g/L when a recombinant strain constructed by using glucose and fructose as a mixed carbon source (introduced from the documents: Stolz M, Peters-Wendisch P, Etterich H, et al. The enhanced expression of 3-phosphoglycerate kinase (PGK) in Corynebacterium glutamicum ATCC13032 by Neisseria scholaris et al increases the synthesis of L-serine precursor 3-phosphoglycerate and improves the yield of L-serine (from the literature: Neisseria scholaris, Zhang Yun, Liu Tree Wen, etc. the metabolic engineering and metabolic flux analysis of Corynebacterium glutamicum producing L-serine [ J ] China science: Life sciences 2012,42(4): 295) 303.).
The inventor screens a wild corynebacterium glutamicum SYPS-062 which can produce L-serine by using sugar raw materials through fermentation in the early stage, and obtains a mutant strain C.glutamicum SYPS-062-33a by taking the wild corynebacterium glutamicum SYPS-062 as an original strain through multiple rounds of chemical mutagenesis. The mutant strain has the advantages that the yield of L-serine is increased by 65 percent and reaches 11.0g/L, and the accumulation of L-alanine and L-valine serving as byproducts is also obviously increased. Further releasing feedback inhibition of key enzyme in an L-serine synthesis pathway on the mutant strain, knocking out a degradation pathway, blocking and weakening a byproduct accumulation pathway, and obtaining the recombinant bacterium C.glutamicum SYPS-06233a delta SSA (abbreviated as delta SSA) (CGMCC NO.8668) with the yield of the L-serine shake flask reaching 26.25g/L which is 3.9 times of that of the wild strain.
Although metabolic engineering of genes for L-serine synthesis and degradation pathways has been very effective, the production of L-serine is currently required to be improved in order to be suitable for industrial scale production. The transport of amino acids out of cells is an important prerequisite for their accumulation in culture media, so transport systems are receiving increasing attention in order to achieve large quantities of amino acids. In recent decades, only 7 proteins have been identified as amino acid secretion transporters in Corynebacterium glutamicum, involving secretion of 13 amino acids. BrnFE participates in the secretion of L-methionine, L-isoleucine, L-valine and L-leucine; CgmA is involved in the secretion of L-arginine; LysE is involved in the secretion of L-lysine, L-arginine, L-citrulline and L-ornithine, MscG is involved in the secretion of L-glutamic acid and L-aspartic acid; MscCG2 is involved in the secretion of L-glutamic acid; only the serE and ThrE proteins were identified as having the function of secretory transport of L-threonine and L-serine.
Disclosure of Invention
In order to solve the technical problems, the invention provides an L-serine transport protein and an application thereof in improving the yield of homoserine.
The first purpose of the invention is to provide an L-serine transporter NCgl0255, wherein the amino acid sequence of the L-serine transporter NCgl0255 is shown as SEQ ID NO. 2.
SEQ ID NO.2:MTTDFSYILLVVAVCAVITFALRAVPFLILKPLRESQFVGKMAMWMPAGILAILTASTFRSNAIDLKTLTFGLIAVAITVAAHLLGSRRTLLSVGAGTIVFVGLVNLF*
In one embodiment of the invention, the nucleotide sequence encoding the L-serine transporter NCgl0255 is shown in SEQ ID No. 1.
SEQ ID NO.1:ATGACAACTGATTTCTCCTATATTCTCCTTGTTGTCGCAGTATGTGCAGTCATTACTTTTGCGCTCCGGGCGGTTCCGTTCTTAATCCTCAAGCCCCTGCGTGAATCACAATTTGTGGGCAAAATGGCGATGTGGATGCCAGCAGGAATCCTTGCCATTTTGACCGCATCAACGTTTCGCAGCAATGCGATAGATCTGAAGACTCTAACCTTTGGTCTCATTGCCGTTGCGATTACAGTGGCGGCGCATCTTCTTGGCAGTCGACGCACCTTGTTGAGCGTTGGCGCTGGCACCATCGTTTTTGTTGGACTGGTGAATCTTTTCTAA。
The second object of the present invention is to provide a gene encoding the L-serine transporter NCgl 0255.
The third purpose of the invention is to provide a plasmid or a vector containing the gene, wherein the vector is selected from a pXMJ19 vector, a pDXW series vector, a pET series vector or a pPICZ series vector.
The fourth object of the present invention is to provide a cell expressing said L-serine transporter NCgl 0255.
In one embodiment of the invention, the host of the cell is Escherichia coli, a coryneform bacterium, a Bacillus, a yeast or a filamentous fungus.
In one embodiment of the invention, the host of the cell is corynebacterium glutamicum SSAAI.
The fifth object of the present invention is to provide a method for increasing the production of L-serine, comprising the steps of: the L-serine transfer protein NCgl0255 of claim 1 is over-expressed in Corynebacterium glutamicum to obtain genetically engineered bacteria over-expressing the L-serine transfer protein NCgl0255, and the genetically engineered bacteria are used for fermentation.
In one embodiment of the invention, the conditions of the fermentation are: the fermentation temperature is 28-32 ℃, and the fermentation is 60-150h under the conditions of 100-140 rpm.
In one embodiment of the invention, the fermentation medium comprises 90-110g/L of sucrose, 20-40g/L of ammonium sulfate, 50-70g/L of calcium carbonate and MgSO4·7H2O 0.5-1g/L,FeSO4·7H2O 0.01-0.05g/L,MnSO4·H20.01-0.05g/L of O, 20-40mg/L of protocatechuic acid, 40-60 mu g/L of biotin and 500 mu g/L of thiamine 400-.
In one embodiment of the invention, the fermentation medium comprises sucrose 100g/L, ammonium sulfate 30g/L, calcium carbonate 60g/L, MgSO4·7H2O 0.5g/L,FeSO4·7H2O 0.02g/L,MnSO4·H2O0.02 g/L, protocatechuic acid 30mg/L, biotin 50. mu.g/L, thiamine 450. mu.g/L, and the initial pH was adjusted to 7.0.
In one embodiment of the invention, the seed medium comprises 37g/L brain heart infusion; 20g/L of glucose; (NH)4)2SO410g/L;MgSO4·7H2O 0.5g/L;K2HPO40.2g/L;NaH2PO40.3g/L。
In one embodiment of the invention, the method for gene knockout in corynebacterium glutamicum Δ SSA comprises the following steps:
the method comprises the following steps: extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
step two: using a genome of delta SSA as a template, using high-fidelity enzyme of Takara company to design a gene knockout specific primer to respectively amplify an upstream sequence and a downstream segment of a target gene, and obtaining a homologous arm segment of target gene deletion by a cross PCR method;
step three: connecting the homologous arm fragment to a corynebacterium glutamicum knock-out plasmid pk18mobsacB to construct a recombinant knock-out plasmid, electrically transferring the recombinant knock-out plasmid into a delta SSA competence, screening by using kanamycin and a 10% sucrose plate, and then verifying by PCR to obtain a recombinant bacterium with a knocked-out gene.
In one embodiment of the invention, the method for overexpression of a gene in corynebacterium glutamicum Δ SSA comprises the following steps:
the method comprises the following steps: extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
step two: using the genome of delta SSA as a template, and using high-fidelity enzyme of Takara company and gene specific primers to amplify to obtain a gene segment;
step three: connecting the target gene fragment with an expression plasmid PDXW-10, constructing an over-expression recombinant plasmid, electrically transferring the over-expression recombinant plasmid into a delta SSA competence, screening recombinant bacteria by using kanamycin, and extracting the plasmid for verification to obtain correct recombinant bacteria.
In one embodiment of the present invention, the recombinant corynebacterium glutamicum fermentation culture method comprises the following steps:
inoculating recombinant corynebacterium glutamicum on a seed plate, carrying out three-region streaking, culturing for 3d, picking out a single colony, carrying out intensive streaking on the seed plate, and culturingAfter 3d, the bacteria on the plate were inoculated into 20mL of seed solution, incubated overnight at 30 ℃ and 120rpm for about 12-16h to OD56225, add to 25mL fermentation medium to OD562Culturing at 120rpm for 5d at 1, 30 deg.C, and measuring OD every 12h562And amino acid concentration.
The sixth purpose of the invention is to provide the application of the L-serine transporter NCgl0255 in the fields of pharmacy, food or cosmetics.
Compared with the prior art, the technical scheme of the invention has the following advantages:
the transport plays an important role in the process of high yield of amino acid by metabolic engineering strain. To date, a variety of amino acid transporters have been found in C.glutamicum, but at present only the transporters ThrE and SerE have been reported to transport L-serine. The invention provides a novel L-serine transport protein NCgl0255, which has a nucleotide sequence shown in SEQ ID NO.1, has the total length of 327 nucleotides, and codes 109 amino acids. By means of genetic engineering, NCgl0255 is overexpressed in Corynebacterium glutamicum delta SSA with high L-serine yield, and the L-serine yield can be increased to 29.58 g/L. The method provides a new idea for improving the L-serine yield by metabolic engineering strain.
Drawings
In order that the present disclosure may be more readily and clearly understood, reference is now made to the following detailed description of the embodiments of the present disclosure taken in conjunction with the accompanying drawings, in which
Fig. 1 is an evaluation of the fermentation characteristics of thrE knockout and overexpression recombinant bacteria, wherein a: recombinant bacteria delta SSA delta thrE; b: the recombinant strain delta SSA-thrE.
FIG. 2 shows the evaluation of fermentation characteristics of NCgl0255 gene knockout recombinant bacteria Δ SSA Δ NCgl 0255.
FIG. 3 is the evaluation of fermentation characteristics of recombinant bacteria Δ SSA-NCgl0255 overexpressing NCgl0255 gene.
FIG. 4 shows the transport function verification of NCgl0255 protein.
Detailed Description
The present invention is further described below in conjunction with the drawings and the embodiments so that those skilled in the art can better understand the present invention and can carry out the present invention, but the embodiments are not to be construed as limiting the present invention.
(I) culture Medium
Seed culture medium: 37g/L of brain-heart infusion; 20g/L of glucose; (NH)4)2SO410g/L;MgSO4·7H2O 0.5g/L;K2HPO40.2g/L;NaH2PO40.3g/L。
Cgxii minimal medium: glucose 40g/L, Urea 5g/L, (NH)4)2SO420g/L,KH2PO41g/L,MgSO40.25g/L,MOPS 42g/L,CaCl210mg/L,FeSO4·7H2O 10mg/L,MnSO4·H2O 10mg/L,ZnSO41mg/L,CuSO40.2mg/L,NiCl2·6H2O0.02 mg/L, biotin 0.2mg/L, protocatechuic acid 0.03 g/L.
Fermentation medium: 100g/L of sucrose, 30g/L of ammonium sulfate, 60g/L of calcium carbonate and MgSO4·7H2O0.5g/L,FeSO4·7H2O 0.02g/L,MnSO4·H2O0.02 g/L, protocatechuic acid 30mg/L, biotin 50. mu.g/L, thiamine 450. mu.g/L, and the initial pH was adjusted to 7.0.
Method for gene knockout in Corynebacterium glutamicum delta SSA
The method comprises the following steps: extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
step two: using a genome of delta SSA as a template, using high-fidelity enzyme of Takara company to design a gene knockout specific primer to respectively amplify an upstream sequence and a downstream segment of a target gene, and obtaining a homologous arm segment of target gene deletion by a cross PCR method;
step three: connecting the homologous arm fragment to a corynebacterium glutamicum knock-out plasmid pk18mobsacB to construct a recombinant knock-out plasmid, electrically transferring the recombinant knock-out plasmid into a delta SSA competence, screening by using kanamycin and a 10% sucrose plate, and then verifying by PCR to obtain a recombinant bacterium with a knocked-out gene.
Method for overexpression of genes in Corynebacterium glutamicum delta SSA
The method comprises the following steps: extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
step two: using a genome of delta SSA as a template, and amplifying by using high-fidelity enzyme of Takara company and gene specific primers to obtain a gene fragment;
step three: connecting the target gene fragment with an expression plasmid PDXW-10, constructing an over-expression recombinant plasmid, electrically transferring the over-expression recombinant plasmid into delta SSA competence, screening recombinant bacteria by using kanamycin, and extracting the plasmid for verification to obtain correct recombinant bacteria.
Fermentation culture method of (IV) recombinant corynebacterium glutamicum
Activating the strain: inoculating recombinant corynebacterium glutamicum on a seed plate, carrying out three-region streaking, culturing for 3d, selecting a single colony, carrying out intensive streaking on the seed plate, culturing for 3d, inoculating bacteria on the plate into 20mL of seed solution, and carrying out overnight culture at 30 ℃ and 120rpm for about 12-16h until OD is reached56225, add to 25mL fermentation Medium to OD562Culturing at 120rpm for 5d at 1, 30 deg.C, and measuring OD every 12h562And amino acid concentration.
(V) verification of L-serine Transporter function
The addition of amino acid dipeptide is a common experimental method for functional verification of amino acid transporters. To verify the L-serine transporter, L-serine dipeptide (L-ser-ser) was synthesized in Nanjing peptide industry for L-serine transport experiments. The corynebacterium glutamicum is activated on a solid seed plate, and then inoculated into a liquid seed culture medium for overnight culture until the growth period reaches the logarithmic phase. Collecting thallus in logarithmic phase, washing with CGXII basic culture medium for 2 times, inoculating to CGXII basic culture medium, adding 3mM L-ser-ser dipeptide, and pre-culturing at 30 deg.C for 2 hr. The pre-cultured cells were collected and washed 2 times with pre-cooled CGXII minimal medium. According to initial OD562The cells were inoculated into 50mL of CGXII minimal medium (8-10) and the transport experiment was started by addition of L-ser-ser dipeptide to a final concentration of 3 mM. Sample 1mL at 15min intervals and leave immediately after samplingThe core and the supernatant were removed and stored in a refrigerator at-80 ℃ for 120 hours, and then the reaction was terminated, followed by measuring the extracellular L-serine concentration by high performance liquid chromatography.
(VI) high performance liquid chromatography for measuring L-serine concentration
1. Solution preparation
Triethylamine acetonitrile: 0.7mL of triethylamine was added to 4.3mL of acetonitrile.
Phenyl isothiocyanate acetonitrile (PITC) solution: 25 μ L of phenylisothiocyanate was added to 2mL of acetonitrile.
Mobile phase A: 15.2g of anhydrous sodium acetate and 1850mL of water were weighed, dissolved, adjusted to pH 6.5 with glacial acetic acid, added with 140mL of acetonitrile, mixed well and filtered through a 0.45 μm organic filter.
Mobile phase B: 80% acetonitrile.
2. Amino acid sample derivatization
Taking 200 mu L of amino acid standard sample and diluted fermentation liquor sample, and adding 20 mu L of norleucine internal standard solution into each tube. Then, 100 mu L of triethylamine acetonitrile and phenyl isothiocyanate acetonitrile solution are respectively added, the mixture is evenly mixed and then stands for 1h at room temperature, 400 mu L of normal hexane is added, the mixture is violently shaken and evenly mixed and then stands for 10min, 200 mu L of lower layer solution is taken out, 800 mu L of ultrapure water is added for dilution, and then sample loading is carried out after filtration by a 0.45 mu m organic filter membrane.
HPLC reaction conditions
And (3) chromatographic column: venusil AA, 4.6X 250nm, 5 μm; violet absorption wavelength: 254 nm; column temperature: 40 ℃; flow rate: 1 mL/min; sample introduction volume: 10 μ L. Gradient elution with mobile phase, wherein the elution procedure is 0-4min, 100% of mobile phase A is 4-16min, 97% of mobile phase A: 16-17min, 89% mobile phase A: 17-32min, 79% mobile phase A; 32-34min, 66% mobile phase A; 34-38min, 0% mobile phase A; 38.01min, 100% mobile phase A.
Corynebacterium glutamicum Δ SSA is disclosed in the literature: metabolic engineering of L-serine Corynebacterium glutamicum SYPS-062 by Royu, university of south Jiangnan, 2012.
Example 1 Effect of L-threonine and L-serine Transporter ThrE on L-serine production by Δ SSA
ThrE is a transporter of L-threonine in C.glutamicum. Since L-threonine and L-serine have chemical structural similarity, ThrE is reported in the literature to also have the effect of transporting serine, and this example illustrates the effect of ThrE on L-serine production by Corynebacterium glutamicum Δ SSA.
1. The thrE knockout was achieved according to the gene knockout method in Corynebacterium glutamicum. DELTA.SSA.
(1) Extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
(2) amplifying the left homologous arm of the target gene by using specific primers thrE-1:5 '-GCTCTAGACATCAATCTGGTCAACGAA and thrE-2: 5' -GACATGGAGATGAGCTAAGAATGCGGCCACGAAGGGTC; amplifying the right homologous arm of the target gene by using specific primers thrE-3:5 '-CTTAGCTCATCTCCATGTCTCAACCCATACCGTGCATT and thrE-4: 5' -CCCAAGCTTATCATCCATATAAGATCCG, and obtaining the homologous arm fragment of the target gene deletion by a cross PCR method;
(3) connecting the homologous arm fragment to a corynebacterium glutamicum knock-out plasmid pk18mobsacB to construct a recombinant knock-out plasmid, electrically transferring the recombinant knock-out plasmid into a delta SSA competence, screening by using kanamycin and a 10% sucrose plate, and then verifying by PCR to obtain a gene-knocked-out recombinant bacterium delta SSA delta thrE.
2. Overexpression of thrE was achieved as described for overexpression in C.glutamicum. DELTA.SSA.
(1) Extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
(2) using the genome of Corynebacterium glutamicum. DELTA SSA as a template, the high-fidelity enzyme of Takara, and a gene-specific primer thrE-F: 5' -GAAGATCTAGAAGGAGATATACCATGTTGAGTTTTGCGACCCT and thrE-R: 5' -CCCAAGCTTTTACCTTTTATTACCGAATC) amplifying to obtain gene segments;
(3) connecting the target gene fragment with an expression plasmid, constructing an over-expression recombinant plasmid, electrically transferring the over-expression recombinant plasmid into a delta SSA competence, screening recombinant bacteria by using kanamycin, and extracting the plasmid for verification to obtain correct recombinant bacteria.
The fermentation characteristics of the recombinant bacteria Δ SSA Δ thrE and Δ SSA-thrE were evaluated in a fermentation medium containing 100g/L sucrose as a substrate, and the results were used to demonstrate the effect of Δ SSA on L-serine production. As can be seen from FIG. 1A, the knockout of the L-threonine transporter, ThrE, did not have a significant effect on strain growth and L-serine production; as can be seen from FIG. 1B, the L-serine production did not increase after over-expressing ThrE, indicating that ThrE, the L-threonine transporter, had no significant effect on increasing L-serine production.
Example 2 Effect of knockout of NCgl0255 Gene on L-serine production by Δ SSA
The transcript levels of NCgl2463 (see SEQ ID NO.3 and SEQ ID NO.4), NCgl0074 (see SEQ ID NO.5 and SEQ ID NO.6) and NCgl0255 (see SEQ ID NO.1 and SEQ ID NO.2) were found to be up-regulated on average by comparison of strain Δ SSA with the transcriptome sequencing of ATCC13032, and it was hypothesized that the genes were associated with the transport of L-serine out of the cell.
The NCgl0255 gene knockout step is as follows:
(1) extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
(2) amplifying the left homologous arm of the target gene by using specific primers NCgl0255-1: CTATGACATGATTACGAATTAGCCAGAAACGTTCACCA and NCgl0255-2: GGTACTTCTTCTTGGCATGCCCTCAATTTGAAGGG; amplifying the right homologous arm of the target gene by using specific primers NCgl0255-3: CAAATTGAGGGCATGCCAAGAAGAAGTACCGGATG and NCgl0255-4: TGCCTGCAGGTCGACTCTAGAATGCTGGTCATCGCCCTC, and obtaining the homologous arm fragment of the target gene deletion by a cross-PCR method;
(3) connecting the homologous arm fragment to a corynebacterium glutamicum knock-out plasmid pk18mobsacB to construct a recombinant knock-out plasmid, electrically transferring the recombinant knock-out plasmid into a delta SSA competence, screening by using kanamycin and a 10% sucrose plate, and then verifying by PCR to obtain a gene-knocked-out recombinant strain delta SSA delta NCgl 0255.
The fermentation characteristics of the recombinant strain Δ SSA Δ NCgl0255 were evaluated in a fermentation medium using 100g/L sucrose as a substrate, and the results are shown in FIG. 2. As can be seen from FIG. 2, the L-serine production was significantly reduced by the knockout of NCgl 0255. After fermentation for 120h, the L-serine accumulation of the recombinant strain delta SSA delta NCgl0255 is 21.7g/L, which is reduced by 17.3% compared with the original strain delta SSA, thus indicating that NCgl0255 is an extremely important transport protein for L-serine.
Example 3 functional verification of the L-serine Transporter NCgl0255
This example is intended to verify the L-serine transport function of the L-serine transporter NCgl 0255.
The addition of amino acid dipeptide is a common experimental method for functional verification of amino acid transporters. To verify the L-serine transporter, L-serine dipeptide (L-ser-ser) was synthesized in Nanjing peptide industry for L-serine transport experiments. Activating corynebacterium glutamicum on a solid seed plate, inoculating the corynebacterium glutamicum into a liquid seed culture medium for overnight culture, and growing to a logarithmic growth phase. Collecting thallus in logarithmic growth phase, washing with CGXII minimal medium for 2 times, inoculating to CGXII minimal medium, adding 3mM L-ser-ser dipeptide, and pre-culturing at 30 deg.C for 2 hr. The pre-cultured cells were collected and washed 2 times with pre-cooled CGXII minimal medium. According to initial OD562The cells were inoculated into 50mL of CGXII minimal medium (8-10) and the transport experiment was started by adding L-ser-ser dipeptide to a final concentration of 3 mM. Sampling 1mL every 15min, immediately centrifuging the sample, taking out the supernatant, storing the supernatant in a refrigerator at-80 ℃, terminating the reaction after 120h, and then measuring the extracellular L-serine concentration by high performance liquid chromatography.
As can be seen from FIG. 3, when L-serine dipeptide was not added to CGXII medium, the L-serine concentration in the recombinant knockout bacterium Δ SSA Δ NCgl0255 medium was reduced by 14.9% as compared to Δ SSA, i.e., the L-serine transport function of the NCgl 0255-knocked protein decreased rapidly, indicating that NCgl0255 has the function of transporting L-serine.
Example 4 enhanced expression of NCgl0255 improves L-serine production
The L-serine transport protein is applied to the research of improving the production of homoserine, and a recombinant bacterium delta SSA-NCgl0255 for enhancing the expression of NCgl0255 is constructed in the corynebacterium glutamicum delta SSA.
The procedure for enhancing expression of NCgl0255 was as follows:
(1) extracting the genome of Corynebacterium glutamicum delta SSA (CGMCC NO.8668) by using a bacterial genome extraction kit of Shanghai Czeri;
(2) using the genome of Corynebacterium glutamicum delta SSA as a template, and using high fidelity enzyme of Takara company and gene specific primers NCgl0255-F:5 '-TTCACACAGGAAACAGAATTCATGACAACTGATTTCTCCTA and NCgl0255-R: 5' -CATCCGCCAAAACAGAAGCTTTTAGAAAAGATTCACCAGTC to amplify to obtain a gene fragment;
(3) connecting the target gene fragment with an expression plasmid, constructing an over-expression recombinant plasmid, electrically transferring the over-expression recombinant plasmid into a delta SSA competence, screening a recombinant bacterium by using kanamycin, and extracting the plasmid for verification to obtain the correct recombinant bacterium delta SSA-0255.
The fermentation characteristics of the recombinant strain Δ SSA-NCgl0255 were evaluated in a fermentation medium using 100g/L sucrose as a substrate, and the results are shown in FIG. 4. As can be seen from FIG. 4, the L-serine accumulation amount was 29.58g/L after over-expression of NCgl0255, which is 12.7% higher than that of the starting strain Δ SSA, indicating that NCgl0255 was successfully applied to increase the L-serine production.
Comparative example 1
Knocking out other proteins NCgl2463 according to a gene knockout method provided by the application to obtain a recombinant bacterium delta SSA delta NCgl 2463.
The fermentation characteristics of the recombinant strain delta SSA delta NCgl2463 are evaluated in a fermentation medium taking 100g/L sucrose as a substrate, and the result shows that after NCgl2463 is knocked out, the strain is knocked out for 120h, the L-serine accumulation amount of the recombinant strain delta SSA delta 2463 is 26.3g/L, compared with the original strain delta SSA, the L-serine is increased by 1.9%, and no significant influence is generated on the growth of the strain and the L-serine yield.
Comparative example 2
Knocking out other proteins NCgl0074 according to a gene knockout method provided by the application to obtain recombinant bacteria delta SSA delta NCgl 0074.
The fermentation characteristics of the recombinant strain delta SSA delta NCgl0074 are evaluated in a fermentation medium taking 100g/L of sucrose as a substrate, and the result shows that after NCgl0074 is knocked out, the strain is knocked out for 120h, the accumulation amount of L-serine of the recombinant strain delta SSA delta Y is 27.5g/L, compared with the original strain delta SSA, the L-serine is increased by 4.8%, and the growth and the yield of the strain are not influenced.
Protein NCgl2463 sequence case:
ATGGCTAACGCCACCGCACAGAAGGGCCGCTTCGGCCTTCCCGGCTGGATGACTGGCTTTGGTGCCCAGGTTATCGCCGGCCTCATTCTTGGCCTTATTCTCGGCCTTGTCGCCCGAGGCATGGACAGCGGCGCTACAGACGGTGAAGCAAGCTGGCTTACCGGTCTTCTTGGCGGCGTCGGTTCTGCTTATGTTTCCCTACTTAAAGTAATGGTTCCACCACTGGTGTTCGCTGCAGTGGTTACCAGTGTGGCAAAGCTGCGCGAGGTAGCTAACGCTGCTCGTCTGGCTGTTTCCACCTTGGTGTGGTTCGCCATTACTGCATTCTTCTCTGTGCTCGCGGGTATCGCCGTAGCGCTGATTATGCAGCCTGGTGTTGGATCCACTGTTGACGCATCTAATGCTGCAGATCCTTCCCATGTTGGCAGCTGGCTGGGCTTTATCCAGTCCGTTATTCCATCAAACATTCTGGGACTTTCCGGTTCTTACAGTGAGAACTCTGGTGTGAACCTGTCCTTCAACGTGCTGCAGATCCTGGTGATCTCCATTGCGATTGGTGTTGCAGCGCTAAAGGCTGGCAAGTCCGCTGAGCCTTTCTTGAAGTTCACCGAGTCCTTCCTCAAGATCATCCAGATAGTGTTGTGGTGGATTATTCGCCTGGCTCCAATTGGTTCCGCTGCGCTGATCGGTAATGCTGTTGCTACCTACGGTTGGTCTGCACTTGGATCCCTGGGCAAGTTTGTTCTTGCGATCTACGTTGGTCTGGCAATCGTCATGTTCGTTATCTACCCAGTCGTGCTGAAGCTCAATGGAATTCCTGTTCTTGGATTCTTTAAGCGCGTTTGGCCTGTCACAAGCCTTGGCTTTGTTACCCGTTCCTCCATGGGCGTTATGCCAGTTACCCAGCGCGTTACTGAGCAGTCCTTGGGTGTTCCATCTGCGTACGCTTCCTTTGCTATCCCACTGGGTGCGACCAGCAAGATGGACGGCTGCGCTGCTGTCTACCCAGCTGTTGCCGCTATCTTCGTGGCACAGTTCTACGGCATTGACTTGAGCATCATGGATTACGTACTGATCATGATCGTCTCTGTCCTGGGCTCTGCTGCTACTGCAGGCACCACTGGCGCAACCGTCATGCTGACCCTGACCCTATCCACCTTGGGTCTGCCACTTGCTGGTGTTGGTCTGCTGCTGGCTATCGAGCCAATCATCGACATGGGACGTACCGCAACCAACGTCACCGGTCAGGCACTGGTTCCTGCGATCGTTGCTAAGCGCGAGGGCATTCTGGATCAGGATGTGTGGGATGCTGCTGAAAAGGGTGGCGCTGCTATTGATAAGGCAACCGTCTCTGAGAAAGAAACTGAGCCTGCAGAGGTTCGCTCCTAA(SEQ ID NO.3)
MANATAQKGRFGLPGWMTGFGAQVIAGLILGLILGLVARGMDSGATDGEASWLTGLLGGVGSAYVSLLKVMVPPLVFAAVVTSVAKLREVANAARLAVSTLVWFAITAFFSVLAGIAVALIMQPGVGSTVDASNAADPSHVGSWLGFIQSVIPSNILGLSGSYSENSGVNLSFNVLQILVISIAIGVAALKAGKSAEPFLKFTESFLKIIQIVLWWIIRLAPIGSAALIGNAVATYGWSALGSLGKFVLAIYVGLAIVMFVIYPVVLKLNGIPVLGFFKRVWPVTSLGFVTRSSMGVMPVTQRVTEQSLGVPSAYASFAIPLGATSKMDGCAAVYPAVAAIFVAQFYGIDLSIMDYVLIMIVSVLGSAATAGTTGATVMLTLTLSTLGLPLAGVGLLLAIEPIIDMGRTATNVTGQALVPAIVAKREGILDQDVWDAAEKGGAAIDKATVSEKETEPAEVRS*(SEQ ID NO.4)。
protein NCgl0074 sequence case:
ATGTCTAACGCATCTTTTAAAGGCGACGATAAAGCACTCATTGGCATAGTTTTATCAGTTCTCACATTTTGGCTTTTTGCTCAGTCAACCCTAAATATCGGCCCAGATATGGCAACTGATTTAGGGATGAGCGATGGCACCATGAACATAGCTGTCGTGGCCGCCGCGTTATTCTGTGGAACATTTATCGTCGCAGCCGGCGGCATCGCAGATGTCTTTGGCCGAGTACGAATCATGATGATTGGCAACATCCTTAACATCCTGGGATCTCTCCTCATCGCCACGGCAACGACTTCTTTAGCCACCCAAATGGTGATCACCGGCCGAGTTCTCCAAGGACTGGCAGCAGCGGCCATCATGTCTGCATCCCTAGCATTAGTTAAGACATATTGGTTAGGTACTGACCGCCAACGAGCAGTCTCCATTTGGTCCATTGGTTCATGGGGTGGCACCGGATTCTGCGCACTTTTCGCGGGTCTTGTTGTAGCAAGCCCCTTTGGCTGGAGAGGAATCTTCGCCCTCTGCGCGATCGTCTCCATCGTTGCTATTGCCCTTACCCGCCACATCCCGGAATCCCGTCCGGCTCAACCCATTGGCATGCACTTGGATTGGAGTGGCATCATCGTTCTTGCCCTCAGTGTTCTATCTCTTGAATTGTTTATTACCCAAGGAGAATCACTTGGCTGGACGCACTGGATGGCCTGGACTCTCCTTGCCGTTTCTTTGACATTTCTCGCTGTTTTCGTCTTCATTGAACGCGTCGCCAGCTGGCCAGTTCTCGACTTCAACCTTTTCAAAGACCACGCCTTCAGCGGTGCGACCATCACCAACTTCATTATGAGCGCTACTGGCGGAGTAGTTGCCGTTGTCATGTGGGTTCAGCAAATGGGATGGGGTGTCTCCCCAACAATCTCGGGACTCACCAGCATCGGCTTCGCAGCCTTTGTCATCCTTTTCATTCGAGTTGGAGAAAAGGCCATGCAGAAAGTTGGCGCCCGAGCAGTGATCATCACCGCTGGCATCTTGGTAGCGACTGCGACCGCCCTCCTAATGATCACCGCAGTCAGCGAGTCAACGTACATCGTCATCTCCCTCGCCGGCTTCTCCCTTTATGGCCTTGGCCTCGGACTCTTCGCCACCCCAGTCACAGATACCGCCCTTGGAACACTTCCCAAAGACCGTACCGGCGCTGGTGCAGGTGTATTCAAGATGTCTTCTTCCCTCGGCGCAGCACTCGGCATCGCAATCTCCACTTCAGTGTTCCTCGCACTTCGCGACGGCACCTCCATCAACTCCGACGTCGCACTCGCCGGAACAGTTTCACTTGGCATCAACGTTGTATTCGCAGCAACAGCCACCATCACCGCAGCAGTCCTTATTCCAAAAGCCGCTGGCAAAGTCTCACAAACCAGCATCACCCTTCCTGAGCCAGCTATCGCTGTAAAAATCTAA(SEQ ID NO.5)。
MSNASFKGDDKALIGIVLSVLTFWLFAQSTLNIGPDMATDLGMSDGTMNIAVVAAALFCGTFIVAAGGIADVFGRVRIMMIGNILNILGSLLIATATTSLATQMVITGRVLQGLAAAAIMSASLALVKTYWLGTDRQRAVSIWSIGSWGGTGFCALFAGLVVASPFGWRGIFALCAIVSIVAIALTRHIPESRPAQPIGMHLDWSGIIVLALSVLSLELFITQGESLGWTHWMAWTLLAVSLTFLAVFVFIERVASWPVLDFNLFKDHAFSGATITNFIMSATGGVVAVVMWVQQMGWGVSPTISGLTSIGFAAFVILFIRVGEKAMQKVGARAVIITAGILVATATALLMITAVSESTYIVISLAGFSLYGLGLGLFATPVTDTALGTLPKDRTGAGAGVFKMSSSLGAALGIAISTSVFLALRDGTSINSDVALAGTVSLGINVVFAATATITAAVLIPKAAGKVSQTSITLPEPAIAVKI*(SEQ ID NO.6)。
it should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications of the invention may be made without departing from the spirit or scope of the invention.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> L-serine transporter and application thereof in improving homoserine production
<130> 6
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 327
<212> DNA
<213> (Artificial Synthesis)
<400> 1
atgacaactg atttctccta tattctcctt gttgtcgcag tatgtgcagt cattactttt 60
gcgctccggg cggttccgtt cttaatcctc aagcccctgc gtgaatcaca atttgtgggc 120
aaaatggcga tgtggatgcc agcaggaatc cttgccattt tgaccgcatc aacgtttcgc 180
agcaatgcga tagatctgaa gactctaacc tttggtctca ttgccgttgc gattacagtg 240
gcggcgcatc ttcttggcag tcgacgcacc ttgttgagcg ttggcgctgg caccatcgtt 300
tttgttggac tggtgaatct tttctaa 327
<210> 2
<211> 108
<212> PRT
<213> (Artificial Synthesis)
<400> 2
Met Thr Thr Asp Phe Ser Tyr Ile Leu Leu Val Val Ala Val Cys Ala
1 5 10 15
Val Ile Thr Phe Ala Leu Arg Ala Val Pro Phe Leu Ile Leu Lys Pro
20 25 30
Leu Arg Glu Ser Gln Phe Val Gly Lys Met Ala Met Trp Met Pro Ala
35 40 45
Gly Ile Leu Ala Ile Leu Thr Ala Ser Thr Phe Arg Ser Asn Ala Ile
50 55 60
Asp Leu Lys Thr Leu Thr Phe Gly Leu Ile Ala Val Ala Ile Thr Val
65 70 75 80
Ala Ala His Leu Leu Gly Ser Arg Arg Thr Leu Leu Ser Val Gly Ala
85 90 95
Gly Thr Ile Val Phe Val Gly Leu Val Asn Leu Phe
100 105
<210> 3
<211> 1389
<212> DNA
<213> (Artificial Synthesis)
<400> 3
atggctaacg ccaccgcaca gaagggccgc ttcggccttc ccggctggat gactggcttt 60
ggtgcccagg ttatcgccgg cctcattctt ggccttattc tcggccttgt cgcccgaggc 120
atggacagcg gcgctacaga cggtgaagca agctggctta ccggtcttct tggcggcgtc 180
ggttctgctt atgtttccct acttaaagta atggttccac cactggtgtt cgctgcagtg 240
gttaccagtg tggcaaagct gcgcgaggta gctaacgctg ctcgtctggc tgtttccacc 300
ttggtgtggt tcgccattac tgcattcttc tctgtgctcg cgggtatcgc cgtagcgctg 360
attatgcagc ctggtgttgg atccactgtt gacgcatcta atgctgcaga tccttcccat 420
gttggcagct ggctgggctt tatccagtcc gttattccat caaacattct gggactttcc 480
ggttcttaca gtgagaactc tggtgtgaac ctgtccttca acgtgctgca gatcctggtg 540
atctccattg cgattggtgt tgcagcgcta aaggctggca agtccgctga gcctttcttg 600
aagttcaccg agtccttcct caagatcatc cagatagtgt tgtggtggat tattcgcctg 660
gctccaattg gttccgctgc gctgatcggt aatgctgttg ctacctacgg ttggtctgca 720
cttggatccc tgggcaagtt tgttcttgcg atctacgttg gtctggcaat cgtcatgttc 780
gttatctacc cagtcgtgct gaagctcaat ggaattcctg ttcttggatt ctttaagcgc 840
gtttggcctg tcacaagcct tggctttgtt acccgttcct ccatgggcgt tatgccagtt 900
acccagcgcg ttactgagca gtccttgggt gttccatctg cgtacgcttc ctttgctatc 960
ccactgggtg cgaccagcaa gatggacggc tgcgctgctg tctacccagc tgttgccgct 1020
atcttcgtgg cacagttcta cggcattgac ttgagcatca tggattacgt actgatcatg 1080
atcgtctctg tcctgggctc tgctgctact gcaggcacca ctggcgcaac cgtcatgctg 1140
accctgaccc tatccacctt gggtctgcca cttgctggtg ttggtctgct gctggctatc 1200
gagccaatca tcgacatggg acgtaccgca accaacgtca ccggtcaggc actggttcct 1260
gcgatcgttg ctaagcgcga gggcattctg gatcaggatg tgtgggatgc tgctgaaaag 1320
ggtggcgctg ctattgataa ggcaaccgtc tctgagaaag aaactgagcc tgcagaggtt 1380
cgctcctaa 1389
<210> 4
<211> 462
<212> PRT
<213> (Artificial Synthesis)
<400> 4
Met Ala Asn Ala Thr Ala Gln Lys Gly Arg Phe Gly Leu Pro Gly Trp
1 5 10 15
Met Thr Gly Phe Gly Ala Gln Val Ile Ala Gly Leu Ile Leu Gly Leu
20 25 30
Ile Leu Gly Leu Val Ala Arg Gly Met Asp Ser Gly Ala Thr Asp Gly
35 40 45
Glu Ala Ser Trp Leu Thr Gly Leu Leu Gly Gly Val Gly Ser Ala Tyr
50 55 60
Val Ser Leu Leu Lys Val Met Val Pro Pro Leu Val Phe Ala Ala Val
65 70 75 80
Val Thr Ser Val Ala Lys Leu Arg Glu Val Ala Asn Ala Ala Arg Leu
85 90 95
Ala Val Ser Thr Leu Val Trp Phe Ala Ile Thr Ala Phe Phe Ser Val
100 105 110
Leu Ala Gly Ile Ala Val Ala Leu Ile Met Gln Pro Gly Val Gly Ser
115 120 125
Thr Val Asp Ala Ser Asn Ala Ala Asp Pro Ser His Val Gly Ser Trp
130 135 140
Leu Gly Phe Ile Gln Ser Val Ile Pro Ser Asn Ile Leu Gly Leu Ser
145 150 155 160
Gly Ser Tyr Ser Glu Asn Ser Gly Val Asn Leu Ser Phe Asn Val Leu
165 170 175
Gln Ile Leu Val Ile Ser Ile Ala Ile Gly Val Ala Ala Leu Lys Ala
180 185 190
Gly Lys Ser Ala Glu Pro Phe Leu Lys Phe Thr Glu Ser Phe Leu Lys
195 200 205
Ile Ile Gln Ile Val Leu Trp Trp Ile Ile Arg Leu Ala Pro Ile Gly
210 215 220
Ser Ala Ala Leu Ile Gly Asn Ala Val Ala Thr Tyr Gly Trp Ser Ala
225 230 235 240
Leu Gly Ser Leu Gly Lys Phe Val Leu Ala Ile Tyr Val Gly Leu Ala
245 250 255
Ile Val Met Phe Val Ile Tyr Pro Val Val Leu Lys Leu Asn Gly Ile
260 265 270
Pro Val Leu Gly Phe Phe Lys Arg Val Trp Pro Val Thr Ser Leu Gly
275 280 285
Phe Val Thr Arg Ser Ser Met Gly Val Met Pro Val Thr Gln Arg Val
290 295 300
Thr Glu Gln Ser Leu Gly Val Pro Ser Ala Tyr Ala Ser Phe Ala Ile
305 310 315 320
Pro Leu Gly Ala Thr Ser Lys Met Asp Gly Cys Ala Ala Val Tyr Pro
325 330 335
Ala Val Ala Ala Ile Phe Val Ala Gln Phe Tyr Gly Ile Asp Leu Ser
340 345 350
Ile Met Asp Tyr Val Leu Ile Met Ile Val Ser Val Leu Gly Ser Ala
355 360 365
Ala Thr Ala Gly Thr Thr Gly Ala Thr Val Met Leu Thr Leu Thr Leu
370 375 380
Ser Thr Leu Gly Leu Pro Leu Ala Gly Val Gly Leu Leu Leu Ala Ile
385 390 395 400
Glu Pro Ile Ile Asp Met Gly Arg Thr Ala Thr Asn Val Thr Gly Gln
405 410 415
Ala Leu Val Pro Ala Ile Val Ala Lys Arg Glu Gly Ile Leu Asp Gln
420 425 430
Asp Val Trp Asp Ala Ala Glu Lys Gly Gly Ala Ala Ile Asp Lys Ala
435 440 445
Thr Val Ser Glu Lys Glu Thr Glu Pro Ala Glu Val Arg Ser
450 455 460
<210> 5
<211> 1452
<212> DNA
<213> (Artificial Synthesis)
<400> 5
atgtctaacg catcttttaa aggcgacgat aaagcactca ttggcatagt tttatcagtt 60
ctcacatttt ggctttttgc tcagtcaacc ctaaatatcg gcccagatat ggcaactgat 120
ttagggatga gcgatggcac catgaacata gctgtcgtgg ccgccgcgtt attctgtgga 180
acatttatcg tcgcagccgg cggcatcgca gatgtctttg gccgagtacg aatcatgatg 240
attggcaaca tccttaacat cctgggatct ctcctcatcg ccacggcaac gacttcttta 300
gccacccaaa tggtgatcac cggccgagtt ctccaaggac tggcagcagc ggccatcatg 360
tctgcatccc tagcattagt taagacatat tggttaggta ctgaccgcca acgagcagtc 420
tccatttggt ccattggttc atggggtggc accggattct gcgcactttt cgcgggtctt 480
gttgtagcaa gcccctttgg ctggagagga atcttcgccc tctgcgcgat cgtctccatc 540
gttgctattg cccttacccg ccacatcccg gaatcccgtc cggctcaacc cattggcatg 600
cacttggatt ggagtggcat catcgttctt gccctcagtg ttctatctct tgaattgttt 660
attacccaag gagaatcact tggctggacg cactggatgg cctggactct ccttgccgtt 720
tctttgacat ttctcgctgt tttcgtcttc attgaacgcg tcgccagctg gccagttctc 780
gacttcaacc ttttcaaaga ccacgccttc agcggtgcga ccatcaccaa cttcattatg 840
agcgctactg gcggagtagt tgccgttgtc atgtgggttc agcaaatggg atggggtgtc 900
tccccaacaa tctcgggact caccagcatc ggcttcgcag cctttgtcat ccttttcatt 960
cgagttggag aaaaggccat gcagaaagtt ggcgcccgag cagtgatcat caccgctggc 1020
atcttggtag cgactgcgac cgccctccta atgatcaccg cagtcagcga gtcaacgtac 1080
atcgtcatct ccctcgccgg cttctccctt tatggccttg gcctcggact cttcgccacc 1140
ccagtcacag ataccgccct tggaacactt cccaaagacc gtaccggcgc tggtgcaggt 1200
gtattcaaga tgtcttcttc cctcggcgca gcactcggca tcgcaatctc cacttcagtg 1260
ttcctcgcac ttcgcgacgg cacctccatc aactccgacg tcgcactcgc cggaacagtt 1320
tcacttggca tcaacgttgt attcgcagca acagccacca tcaccgcagc agtccttatt 1380
ccaaaagccg ctggcaaagt ctcacaaacc agcatcaccc ttcctgagcc agctatcgct 1440
gtaaaaatct aa 1452
<210> 6
<211> 483
<212> PRT
<213> (Artificial Synthesis)
<400> 6
Met Ser Asn Ala Ser Phe Lys Gly Asp Asp Lys Ala Leu Ile Gly Ile
1 5 10 15
Val Leu Ser Val Leu Thr Phe Trp Leu Phe Ala Gln Ser Thr Leu Asn
20 25 30
Ile Gly Pro Asp Met Ala Thr Asp Leu Gly Met Ser Asp Gly Thr Met
35 40 45
Asn Ile Ala Val Val Ala Ala Ala Leu Phe Cys Gly Thr Phe Ile Val
50 55 60
Ala Ala Gly Gly Ile Ala Asp Val Phe Gly Arg Val Arg Ile Met Met
65 70 75 80
Ile Gly Asn Ile Leu Asn Ile Leu Gly Ser Leu Leu Ile Ala Thr Ala
85 90 95
Thr Thr Ser Leu Ala Thr Gln Met Val Ile Thr Gly Arg Val Leu Gln
100 105 110
Gly Leu Ala Ala Ala Ala Ile Met Ser Ala Ser Leu Ala Leu Val Lys
115 120 125
Thr Tyr Trp Leu Gly Thr Asp Arg Gln Arg Ala Val Ser Ile Trp Ser
130 135 140
Ile Gly Ser Trp Gly Gly Thr Gly Phe Cys Ala Leu Phe Ala Gly Leu
145 150 155 160
Val Val Ala Ser Pro Phe Gly Trp Arg Gly Ile Phe Ala Leu Cys Ala
165 170 175
Ile Val Ser Ile Val Ala Ile Ala Leu Thr Arg His Ile Pro Glu Ser
180 185 190
Arg Pro Ala Gln Pro Ile Gly Met His Leu Asp Trp Ser Gly Ile Ile
195 200 205
Val Leu Ala Leu Ser Val Leu Ser Leu Glu Leu Phe Ile Thr Gln Gly
210 215 220
Glu Ser Leu Gly Trp Thr His Trp Met Ala Trp Thr Leu Leu Ala Val
225 230 235 240
Ser Leu Thr Phe Leu Ala Val Phe Val Phe Ile Glu Arg Val Ala Ser
245 250 255
Trp Pro Val Leu Asp Phe Asn Leu Phe Lys Asp His Ala Phe Ser Gly
260 265 270
Ala Thr Ile Thr Asn Phe Ile Met Ser Ala Thr Gly Gly Val Val Ala
275 280 285
Val Val Met Trp Val Gln Gln Met Gly Trp Gly Val Ser Pro Thr Ile
290 295 300
Ser Gly Leu Thr Ser Ile Gly Phe Ala Ala Phe Val Ile Leu Phe Ile
305 310 315 320
Arg Val Gly Glu Lys Ala Met Gln Lys Val Gly Ala Arg Ala Val Ile
325 330 335
Ile Thr Ala Gly Ile Leu Val Ala Thr Ala Thr Ala Leu Leu Met Ile
340 345 350
Thr Ala Val Ser Glu Ser Thr Tyr Ile Val Ile Ser Leu Ala Gly Phe
355 360 365
Ser Leu Tyr Gly Leu Gly Leu Gly Leu Phe Ala Thr Pro Val Thr Asp
370 375 380
Thr Ala Leu Gly Thr Leu Pro Lys Asp Arg Thr Gly Ala Gly Ala Gly
385 390 395 400
Val Phe Lys Met Ser Ser Ser Leu Gly Ala Ala Leu Gly Ile Ala Ile
405 410 415
Ser Thr Ser Val Phe Leu Ala Leu Arg Asp Gly Thr Ser Ile Asn Ser
420 425 430
Asp Val Ala Leu Ala Gly Thr Val Ser Leu Gly Ile Asn Val Val Phe
435 440 445
Ala Ala Thr Ala Thr Ile Thr Ala Ala Val Leu Ile Pro Lys Ala Ala
450 455 460
Gly Lys Val Ser Gln Thr Ser Ile Thr Leu Pro Glu Pro Ala Ile Ala
465 470 475 480
Val Lys Ile

Claims (10)

1. An L-serine transporter NCgl0255, wherein the amino acid sequence of the L-serine transporter NCgl0255 is shown as SEQ ID No. 2.
2. A gene encoding the L-serine transporter NCgl0255 of claim 1.
3. A plasmid or vector containing the gene of claim 2, wherein the vector is selected from the group consisting of pXMJ19 vector, pDXW series vector, pET series vector, and pPICZ series vector.
4. A cell expressing the L-serine transporter NCgl0255 of claim 1.
5. The cell of claim 4, wherein the host of the cell is Escherichia coli, a coryneform bacterium, a Bacillus, a yeast, or a filamentous fungus.
6. The cell of claim 4, wherein the host of the cell is Corynebacterium glutamicum SSAAI.
7. A method for improving the yield of L-serine, which is characterized by comprising the following steps: the L-serine transfer protein NCgl0255 of claim 1 is over-expressed in Corynebacterium glutamicum to obtain genetically engineered bacteria over-expressing the L-serine transfer protein NCgl0255, and the genetically engineered bacteria are used for fermentation.
8. The method according to claim 7, characterized in that the conditions of the fermentation are: the fermentation temperature is 28-32 ℃, and the fermentation is carried out for 60-150h under the conditions of 100-.
9. The method of claim 1, wherein the fermentation medium comprises sucrose 90-110g/L, ammonium sulfate 20-40g/L, calcium carbonate 50-70g/L, MgSO4·7H2O 0.5-1g/L,FeSO4·7H2O 0.01-0.05g/L,MnSO4·H20.01-0.05g/L of O, 20-40mg/L of protocatechuic acid, 40-60 mu g/L of biotin and 500 mu g/L of thiamine 400-ketone.
10. Use of the L-serine transporter NCgl0255 according to claim 1 in the pharmaceutical, food or cosmetic field.
CN202210515655.7A 2022-05-12 2022-05-12 L-serine transport protein and application thereof in improving homoserine yield Active CN114716519B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210515655.7A CN114716519B (en) 2022-05-12 2022-05-12 L-serine transport protein and application thereof in improving homoserine yield

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210515655.7A CN114716519B (en) 2022-05-12 2022-05-12 L-serine transport protein and application thereof in improving homoserine yield

Publications (2)

Publication Number Publication Date
CN114716519A true CN114716519A (en) 2022-07-08
CN114716519B CN114716519B (en) 2023-02-10

Family

ID=82230909

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210515655.7A Active CN114716519B (en) 2022-05-12 2022-05-12 L-serine transport protein and application thereof in improving homoserine yield

Country Status (1)

Country Link
CN (1) CN114716519B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376210B1 (en) * 1999-07-06 2002-04-23 General Atomics Methods and compositions for assaying analytes
CN104004678A (en) * 2014-05-05 2014-08-27 江南大学 Construction of corynebacterium glutamicum engineering bacteria for high-yielding production of L-valine and method for fermentation production of L-valine
CN108330095A (en) * 2018-03-01 2018-07-27 江南大学 It is a kind of accumulation N-acetyl-neuraminate recombination Corynebacterium glutamicum and its application
CN108486133A (en) * 2018-06-29 2018-09-04 江南大学 A kind of application process of Serine transport protein
CN110590920A (en) * 2019-09-30 2019-12-20 江南大学 L-serine transport protein and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376210B1 (en) * 1999-07-06 2002-04-23 General Atomics Methods and compositions for assaying analytes
CN104004678A (en) * 2014-05-05 2014-08-27 江南大学 Construction of corynebacterium glutamicum engineering bacteria for high-yielding production of L-valine and method for fermentation production of L-valine
CN108330095A (en) * 2018-03-01 2018-07-27 江南大学 It is a kind of accumulation N-acetyl-neuraminate recombination Corynebacterium glutamicum and its application
CN108486133A (en) * 2018-06-29 2018-09-04 江南大学 A kind of application process of Serine transport protein
CN110590920A (en) * 2019-09-30 2019-12-20 江南大学 L-serine transport protein and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GENBANK DATABASE: "ACCESSION ID:WP_003855740.1,MULTISPECIES: branched-chain amino acid exporter BrnE [Corynebacterium]", 《GENBANK DATABASE》 *

Also Published As

Publication number Publication date
CN114716519B (en) 2023-02-10

Similar Documents

Publication Publication Date Title
CN108486133B (en) Application method of L-serine transport protein
CN110590920B (en) L-serine transport protein and application thereof
TWI718385B (en) Novel aspartokinase variant and method for producing l-amino acid using the same
CN109536428B (en) Genetically engineered bacterium for producing L-isoleucine and construction method and application thereof
JP2019528075A (en) New promoters and their uses
CN106754807B (en) L-leucine producing strain and method for producing L-leucine
KR101504900B1 (en) A Mutation of Transketolase gene Promoter and Use thereof
CN108330095B (en) Recombinant corynebacterium glutamicum for accumulating N-acetylneuraminic acid and application thereof
CN111849794A (en) Saccharomyces cerevisiae recombinant strain and construction method and application thereof
CN111471638A (en) Construction and application of corynebacterium glutamicum mutant strain capable of producing L-homoserine
WO2012172822A1 (en) Recombinant microorganism, and method for producing alanine using said recombinant microorganism
CN109456987B (en) High-yield L-leucine related gene and engineering bacterium construction method and application
EP4183881A1 (en) Mutant of pyruvate carboxylase gene promoter and use thereof
CN114716519B (en) L-serine transport protein and application thereof in improving homoserine yield
US11293014B2 (en) Microorganism for producing L-amino acid with enhanced activity of α-glucosidase and method for producing L-amino acid using the same
KR20100124793A (en) Recombinant microorganism and method for producing l-lysine
EP4190904A1 (en) L-valine-producing microorganisms and l-valine producing method using same
EP3279327A1 (en) Novel promoter and use for same
CN113402593A (en) L-threonine transport protein and coding gene and application thereof
CN110862940A (en) Corynebacterium glutamicum engineering bacterium and application thereof in preparation of L-tryptophan
RU2812048C9 (en) Pyruvate carboxylase gene promoter mutant and its application
RU2812048C1 (en) Pyruvate carboxylase gene promoter mutant and its application
CN116904414A (en) Trehalose-6-phosphate phosphatase mutant and application thereof
CN116970545A (en) Genetically engineered bacterium for producing tetrahydropyrimidine and construction method and application thereof
CN116949108A (en) L-glutamine exoprotein, mutant thereof and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant